NCT02190409

Brief Summary

The purpose of this study was to evaluate the effects of (Platelet Rich Fibrin) PRF application on implant osseointegration in the early phase of healing.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2011

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2012

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

July 8, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 15, 2014

Completed
Last Updated

July 15, 2014

Status Verified

July 1, 2014

Enrollment Period

1 month

First QC Date

July 8, 2014

Last Update Submit

July 14, 2014

Conditions

Keywords

Dental Implant,

Outcome Measures

Primary Outcomes (1)

  • Implant Stabilitty Quotient (ISQ) evaluation: analysis of the resonance frequency values 4 week period.

    The stability of the implants were evaluated with the resonance frequency analysis (RFA) method. The measurements were carried out with Osstell ISQ (Implant Stability Quotient) (Osstell, Göteborg, Sweden) by connecting the transducer (smartpeg) to the implant. Two mesio-distal and bucco-lingual measurements were recorded and mean ISQ values were calculated. The resonance frequency measurements were repeated at first and fourth weeks.

    Resonance frequency measurements were made by Osstell ISQ after placement of implants, at 1 week and one month postoperatively.

Secondary Outcomes (1)

  • Evaluation of osseointegration in different types of bone

    Resonance frequency measurements in different bone types were made by Osstell ISQ after placement of implants, at 1 week and one month postoperatively.

Study Arms (1)

Test, Control

EXPERIMENTAL

Test: Minimum two tapered implants (Ankylosis, Dentsply Friadent) were placed to each patient. After surgical preparation of implant sockets, PRF that was prepared preoperatively was placed randomly to one of the sockets (PRF+). Acellular plasma portion of PRF was used to wet the implant placed into the PRF-coated socket Control: Other socket was selected as a control group (No Platelet Rich Fibrin used): In the control group no extra intervention used and the conventional procedure was done. Thus the readings of the experimental arm compared with this control.

Device: Dental implant

Interventions

This longitudinal human clinical trial is designed to measure implant stability with the resonance frequency analyzer (Osstell, Integration Diagnostics AB, Sweden) at time of implant placement and up to 4 weeks post placement. delivered. No further follow-up will be done with the resonance frequency approach

Also known as: The implant in this protocol, 3.5 mm width and 11 mm length) ANKYLOS C/X dental implants were used (Dentsply, Hanau, Germany
Test, Control

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • The absence of any lesions in the oral cavity, and sufficient residual bone volume to receive two or more adjacent implants of ≥3.5 mm in diameter and 11.0 mm in length, and extracted at least 6 months ago.

You may not qualify if:

  • Insufficient bone volume
  • Parafunctional habits
  • Smoking more than 10 cigarettes per day
  • Excessive consumption of alcohol
  • Localized radiotherapy of the oral cavity
  • Antitumor chemotherapy
  • Liver, blood, and kidney diseases
  • Immunosuppression
  • Current corticosteroid or bisphosphonate use
  • Pregnancy
  • Mucocutaneous diseases involving oral cavity
  • Poor oral hygiene

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NECMETTIN ERBAKAN University Faculty of Dentistry, Department of Periodontology,

Ankara, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Dental Implants

Intervention Hierarchy (Ancestors)

Dental MaterialsBiomedical and Dental MaterialsDental ProsthesisProsthodonticsDentistryProstheses and ImplantsEquipment and SuppliesManufactured MaterialsTechnology, Industry, and Agriculture

Study Officials

  • ELİF ÖNCÜ, 1

    NECMETTİN ERBAKAN UNIVERSITY

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assist.Prof.Dr.

Study Record Dates

First Submitted

July 8, 2014

First Posted

July 15, 2014

Study Start

December 1, 2011

Primary Completion

January 1, 2012

Study Completion

December 1, 2012

Last Updated

July 15, 2014

Record last verified: 2014-07

Locations